Skip to main content
Top

Open Access 06-05-2024 | Ulcerative Colitis | RESEARCH

Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection

Authors: B. Schiller, E. Wirthgen, F. Weber, S. Schiller, M. Radke, M. Claßen, J. Däbritz, CEDATA-GPGE Study Group

Published in: European Journal of Pediatrics

Login to get access

Abstract

Especially for pediatric patients, proxies of mucosal inflammation are needed. The Pediatric Ulcerative Colitis Activity Index (PUCAI) has been established to predict clinical and endoscopic disease activity. However, histologic inflammation might persist. We applied a special variable selection technique to predict histologic healing in pediatric ulcerative colitis (UC) as parsimoniously (but still as precisely) as possible. The retrospective analysis included data from two study cohorts, comprising 91 visits from 59 pediatric patients with UC. A Bayesian ordinal regression model was used in combination with a projection-predictive feature selection (PPFS) to identify a minimal subset of clinical and laboratory parameters sufficient for the prediction of histologic disease activity. Following the PPFS, CEDATA-GPGE patient registry data were analyzed to investigate the relevance of the selected predictors in relation to PUCAI and Physician Global Assessment (PGA) in up to 6697 patient visits. Fecal calprotectin (FC) and platelet count were identified as the minimal subset of predictors sufficient for prediction of histologic disease activity in pediatric UC. FC and platelet count also appeared to be associated with increasing disease activity as measured by PUCAI and PGA in the CEDATA-GPGE registry. Based on the selected model, predictions can be performed with a Shiny web app.
  Conclusion: Our statistical approach constitutes a reproducible and objective tool to select a minimal subset of the most informative parameters to predict histologic inflammation in pediatric UC. A Shiny app shows how physicians may predict the histologic activity in a user-friendly way using FC and platelet count. To generalize the findings, further prospective studies will be needed.
What is Known:
• Histologic healing is a major endpoint in the therapy of ulcerative colitis (UC).
• The PUCAI score has been established to predict disease activity in pediatric UC but is not suitable for the prediction of histologic healing.
What is New:
• Our Bayesian ordinal regression model in combination with a projection-predictive feature selection is a reproducible and objective tool to select the minimal subset of clinical and laboratory parameters to predict histologic inflammation in pediatric UC.
• Histologic inflammation in pediatric UC can be non-invasively predicted based on the combination of fecal calprotectin levels and platelet count.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado DF, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI (2022) Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: Systematic review. Gastroenterology 162:1147–1159.e4. https://doi.org/10.1053/j.gastro.2021.12.282CrossRefPubMed Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado DF, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI (2022) Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: Systematic review. Gastroenterology 162:1147–1159.e4. https://​doi.​org/​10.​1053/​j.​gastro.​2021.​12.​282CrossRefPubMed
10.
go back to reference Ma C, Sedano R, Almradi A, Vande Casteele N, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R, Sands BE, Rosty C, Dubinsky MC, Rieder F, Harpaz N, Abreu MT, Bryant RV, Lauwers GY, Kirsch R, Valasek MA, Crowley E, Sandborn WJ, Feagan BG, Pai RK, Jairath V (2021) An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. Gastroenterology 160:2291–2302. https://doi.org/10.1053/j.gastro.2021.02.035CrossRefPubMed Ma C, Sedano R, Almradi A, Vande Casteele N, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R, Sands BE, Rosty C, Dubinsky MC, Rieder F, Harpaz N, Abreu MT, Bryant RV, Lauwers GY, Kirsch R, Valasek MA, Crowley E, Sandborn WJ, Feagan BG, Pai RK, Jairath V (2021) An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. Gastroenterology 160:2291–2302. https://​doi.​org/​10.​1053/​j.​gastro.​2021.​02.​035CrossRefPubMed
11.
go back to reference Magro F, Doherty G, Peyrin-Biroulet L, Svrcek M, Borralho P, Walsh A, Carneiro F, Rosini F, de Hertogh G, Biedermann L, Pouillon L, Scharl M, Tripathi M, Danese S, Villanacci V, Feakins R (2020) ECCO position paper: harmonization of the approach to ulcerative colitis histopathology. J Crohns Colitis 14:1503–1511. https://doi.org/10.1093/ecco-jcc/jjaa110CrossRefPubMed Magro F, Doherty G, Peyrin-Biroulet L, Svrcek M, Borralho P, Walsh A, Carneiro F, Rosini F, de Hertogh G, Biedermann L, Pouillon L, Scharl M, Tripathi M, Danese S, Villanacci V, Feakins R (2020) ECCO position paper: harmonization of the approach to ulcerative colitis histopathology. J Crohns Colitis 14:1503–1511. https://​doi.​org/​10.​1093/​ecco-jcc/​jjaa110CrossRefPubMed
13.
go back to reference Thomson M, Tringali A, Dumonceau J-M, Tavares M, Tabbers MM, Furlano R, Spaander M, Hassan C, Tzvinikos C, Ijsselstijn H, Viala J, Dall’Oglio L, Benninga M, Orel R, Vandenplas Y, Keil R, Romano C, Brownstone E, Hlava Š, Gerner P, Dolak W, Landi R, Huber WD, Everett S, Vecsei A, Aabakken L, Amil-Dias J, Zambelli A (2017) Paediatric gastrointestinal endoscopy: European society for paediatric gastroenterology hepatology and nutrition and European society of gastrointestinal endoscopy guidelines. J Pediatr Gastroenterol Nutr 64:133–153. https://doi.org/10.1097/MPG.0000000000001408CrossRefPubMed Thomson M, Tringali A, Dumonceau J-M, Tavares M, Tabbers MM, Furlano R, Spaander M, Hassan C, Tzvinikos C, Ijsselstijn H, Viala J, Dall’Oglio L, Benninga M, Orel R, Vandenplas Y, Keil R, Romano C, Brownstone E, Hlava Š, Gerner P, Dolak W, Landi R, Huber WD, Everett S, Vecsei A, Aabakken L, Amil-Dias J, Zambelli A (2017) Paediatric gastrointestinal endoscopy: European society for paediatric gastroenterology hepatology and nutrition and European society of gastrointestinal endoscopy guidelines. J Pediatr Gastroenterol Nutr 64:133–153. https://​doi.​org/​10.​1097/​MPG.​0000000000001408​CrossRefPubMed
20.
22.
go back to reference Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK (2018) Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 67:257–291. https://doi.org/10.1097/MPG.0000000000002035CrossRefPubMed Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK (2018) Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 67:257–291. https://​doi.​org/​10.​1097/​MPG.​0000000000002035​CrossRefPubMed
23.
go back to reference Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel J-F, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A (2021) STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160:1570–1583. https://doi.org/10.1053/j.gastro.2020.12.031CrossRefPubMed Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel J-F, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A (2021) STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160:1570–1583. https://​doi.​org/​10.​1053/​j.​gastro.​2020.​12.​031CrossRefPubMed
24.
go back to reference Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J (2019) ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144–164. https://doi.org/10.1093/ecco-jcc/jjy113CrossRefPubMed Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J (2019) ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144–164. https://​doi.​org/​10.​1093/​ecco-jcc/​jjy113CrossRefPubMed
26.
go back to reference Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho K-L, Veres G, Russell RK, Paerregaard A, Buderus S, Greer M-LC, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC (2014) ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 58:795–806. https://doi.org/10.1097/MPG.0000000000000239CrossRefPubMed Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho K-L, Veres G, Russell RK, Paerregaard A, Buderus S, Greer M-LC, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC (2014) ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 58:795–806. https://​doi.​org/​10.​1097/​MPG.​0000000000000239​CrossRefPubMed
29.
37.
go back to reference Catalina A, Bürkner PC, Vehtari A (2022) Projection predictive inference for generalized linear and additive multilevel models. In: Camps-Valls G, Ruiz FJ, Valera I, editors. Proceedings of The 25th International Conference on Artificial Intelligence and Statistics. PMLR, virtual conference 2022 151:4446–4461. Available at: https://proceedings.mlr.press/v151/catalina22a.html Catalina A, Bürkner PC, Vehtari A (2022) Projection predictive inference for generalized linear and additive multilevel models. In: Camps-Valls G, Ruiz FJ, Valera I, editors. Proceedings of The 25th International Conference on Artificial Intelligence and Statistics. PMLR, virtual conference 2022 151:4446–4461. Available at: https://​proceedings.​mlr.​press/​v151/​catalina22a.​html
40.
go back to reference IBM Corp (2022) IBM SPSS Statistics, for Macintosh, Version 29.0. Armonk, NY: IBM Corp IBM Corp (2022) IBM SPSS Statistics, for Macintosh, Version 29.0. Armonk, NY: IBM Corp
42.
go back to reference D’Amico F, Magro F, Siegmund B, Kobayashi T, Kotze PG, Solitano V, Caron B, Al Awadhi S, Hart A, Jairath V, Dignass A, Peyrin-Biroulet L, Danese, Silvio, on behalf of the end point cluster of the International Organization for the Study of Inflammatory Bowel Diseases (2023) Disease clearance as a new outcome in ulcerative colitis: a systematic review and expert consensus. Inflamm Bowel Dis izad159. https://doi.org/10.1093/ibd/izad159 D’Amico F, Magro F, Siegmund B, Kobayashi T, Kotze PG, Solitano V, Caron B, Al Awadhi S, Hart A, Jairath V, Dignass A, Peyrin-Biroulet L, Danese, Silvio, on behalf of the end point cluster of the International Organization for the Study of Inflammatory Bowel Diseases (2023) Disease clearance as a new outcome in ulcerative colitis: a systematic review and expert consensus. Inflamm Bowel Dis izad159. https://​doi.​org/​10.​1093/​ibd/​izad159
43.
45.
go back to reference Magro F, Alves C, Lopes J, Lopes S, Tavares de Sousa H, Cotter J, Da Macedo SV, Lago P, Vieira A, Brito M, Duarte MAM, Portela F, Silva JP, Ministro P, Arroja B, Carvalho L, Torres J, Santiago M, Estevinho MM, Danese S, Peyrin-Biroulet L, Dias CC, Borralho P, Feakins RM, Carneiro F (2021) Histologic features of colon biopsies (Geboes score) associated with progression of ulcerative colitis for the First 36 months after biopsy. Clin Gastroenterol Hepatol 19:2567-2576.e9. https://doi.org/10.1016/j.cgh.2020.09.017CrossRefPubMed Magro F, Alves C, Lopes J, Lopes S, Tavares de Sousa H, Cotter J, Da Macedo SV, Lago P, Vieira A, Brito M, Duarte MAM, Portela F, Silva JP, Ministro P, Arroja B, Carvalho L, Torres J, Santiago M, Estevinho MM, Danese S, Peyrin-Biroulet L, Dias CC, Borralho P, Feakins RM, Carneiro F (2021) Histologic features of colon biopsies (Geboes score) associated with progression of ulcerative colitis for the First 36 months after biopsy. Clin Gastroenterol Hepatol 19:2567-2576.e9. https://​doi.​org/​10.​1016/​j.​cgh.​2020.​09.​017CrossRefPubMed
47.
52.
go back to reference Janker L, Schuster D, Bortel P, Hagn G, Meier-Menches SM, Mohr T, Mader JC, Slany A, Bileck A, Brunmair J, Madl C, Unger L, Hennlich B, Weitmayr B, Del Favero G, Pils D, Pukrop T, Pfisterer N, Feichtenschlager T, Gerner C (2023) Multiomics-empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states. J Crohns Colitis 17:1514–1527. https://doi.org/10.1093/ecco-jcc/jjad052CrossRefPubMedPubMedCentral Janker L, Schuster D, Bortel P, Hagn G, Meier-Menches SM, Mohr T, Mader JC, Slany A, Bileck A, Brunmair J, Madl C, Unger L, Hennlich B, Weitmayr B, Del Favero G, Pils D, Pukrop T, Pfisterer N, Feichtenschlager T, Gerner C (2023) Multiomics-empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states. J Crohns Colitis 17:1514–1527. https://​doi.​org/​10.​1093/​ecco-jcc/​jjad052CrossRefPubMedPubMedCentral
62.
go back to reference Iacucci M, Parigi TL, Del Amor R, Meseguer P, Mandelli G, Bozzola A, Bazarova A, Bhandari P, Bisschops R, Danese S, de Hertogh G, Ferraz JG, Goetz M, Grisan E, Gui X, Hayee B, Kiesslich R, Lazarev M, Panaccione R, Parra-Blanco A, Pastorelli L, Rath T, Røyset ES, Tontini GE, Vieth M, Zardo D, Ghosh S, Naranjo V, Villanacci V (2023) Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. Gastroenterology 164:1180-1188.e2. https://doi.org/10.1053/j.gastro.2023.02.031CrossRefPubMed Iacucci M, Parigi TL, Del Amor R, Meseguer P, Mandelli G, Bozzola A, Bazarova A, Bhandari P, Bisschops R, Danese S, de Hertogh G, Ferraz JG, Goetz M, Grisan E, Gui X, Hayee B, Kiesslich R, Lazarev M, Panaccione R, Parra-Blanco A, Pastorelli L, Rath T, Røyset ES, Tontini GE, Vieth M, Zardo D, Ghosh S, Naranjo V, Villanacci V (2023) Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. Gastroenterology 164:1180-1188.e2. https://​doi.​org/​10.​1053/​j.​gastro.​2023.​02.​031CrossRefPubMed
Metadata
Title
Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection
Authors
B. Schiller
E. Wirthgen
F. Weber
S. Schiller
M. Radke
M. Claßen
J. Däbritz
CEDATA-GPGE Study Group
Publication date
06-05-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-024-05554-y